“…[115] The inhibition of the corresponding oxidation of cysteamine (84) with Fe(III) chloride or chloropicrin may be attributed to pathway 2, but pathway 1 may be at play when oxygen is the oxidizing agent, [114] when CB [6] prevents hydrogen peroxide oxidation of selenocystamine (85) to selenous acid 87, [115] or when CB [7] encapsulation of the alkanolamine form of sanguinarin 76 prevents its photo oxidation to 6-oxysanguinarine (88) by oxygen. [35,116] Since the seminal work by Mock and coworkers in 1989 describing [3 + 2] alkyne-azide cycloadditions catalyzed with CB [6] [117] and subsequent applications, [77,118,119] a large number of studies have shown the potential of the CB[n] family members to promote reactions within their cavity or at their portal, and a majority of those propose solid rationales for the observed rate changes. We take the advantage here to highlight the remarkable and very recent functionalization of proteins by Francis and coworkers, who managed to prepare protein À DNA, protein À peptide, protein À polymer, and protein À drug conjugates using the CB[6]-catalyzed alkyne-azide cycloaddition.…”